Literature DB >> 11463341

A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors.

M C Walker1, R G Kurumbail, J R Kiefer, K T Moreland, C M Koboldt, P C Isakson, K Seibert, J K Gierse.   

Abstract

Cyclo-oxygenase (COX) enzymes are the targets for non-steroidal anti-inflammatory drugs (NSAIDs). These drugs demonstrate a variety of inhibitory mechanisms, which include simple competitive, as well as slow binding and irreversible inhibition. In general, most NSAIDs inhibit COX-1 and -2 by similar mechanisms. A unique class of diarylheterocyclic inhibitors has been developed that is highly selective for COX-2 by virtue of distinct inhibitory mechanisms for each isoenzyme. Several of these inhibitors, with varying selectivity, have been utilized to probe the mechanisms of COX inhibition. Results from analysis of both steady-state and time-dependent inhibition were compared. A generalized mechanism for inhibition, consisting of three sequential reversible steps, can account for the various types of kinetic behaviour observed with these inhibitors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11463341      PMCID: PMC1222000          DOI: 10.1042/0264-6021:3570709

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase.

Authors:  R KITZ; I B WILSON
Journal:  J Biol Chem       Date:  1962-10       Impact factor: 5.157

Review 2.  Prostaglandin endoperoxide synthase: structure and catalysis.

Authors:  W L Smith; L J Marnett
Journal:  Biochim Biophys Acta       Date:  1991-04-24

3.  Fluorescence quenching analysis of the association and dissociation of a diarylheterocycle to cyclooxygenase-1 and cyclooxygenase-2: dynamic basis of cyclooxygenase-2 selectivity.

Authors:  C A Lanzo; J Sutin; S Rowlinson; J Talley; L J Marnett
Journal:  Biochemistry       Date:  2000-05-23       Impact factor: 3.162

Review 4.  The behavior and significance of slow-binding enzyme inhibitors.

Authors:  J F Morrison; C T Walsh
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1988

5.  The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1.

Authors:  D Picot; P J Loll; R M Garavito
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

6.  Kinetics of factor Xa inhibition by tissue factor pathway inhibitor.

Authors:  Z F Huang; T C Wun; G J Broze
Journal:  J Biol Chem       Date:  1993-12-25       Impact factor: 5.157

7.  NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.

Authors:  N Futaki; S Takahashi; M Yokoyama; I Arai; S Higuchi; S Otomo
Journal:  Prostaglandins       Date:  1994-01

8.  Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor.

Authors:  K R Gans; W Galbraith; R J Roman; S B Haber; J S Kerr; W K Schmidt; C Smith; W E Hewes; N R Ackerman
Journal:  J Pharmacol Exp Ther       Date:  1990-07       Impact factor: 4.030

9.  Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs.

Authors:  L H Rome; W E Lands
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

10.  Acetylation of prostaglandin endoperoxide synthetase with acetylsalicylic acid.

Authors:  F J Van Der Ouderaa; M Buytenhek; D H Nugteren; D A Van Dorp
Journal:  Eur J Biochem       Date:  1980-08
View more
  19 in total

Review 1.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

Review 2.  Recent methodologies toward the synthesis of valdecoxib: a potential 3,4-diarylisoxazolyl COX-II inhibitor.

Authors:  Sureshbabu Dadiboyena; Adel Nefzi
Journal:  Eur J Med Chem       Date:  2010-08-06       Impact factor: 6.514

3.  A computational protocol for the integration of the monotopic protein prostaglandin H2 synthase into a phospholipid bilayer.

Authors:  Philip W Fowler; Peter V Coveney
Journal:  Biophys J       Date:  2006-04-21       Impact factor: 4.033

4.  Synthesis and kinetic analysis of some phosphonate analogs of cyclophostin as inhibitors of human acetylcholinesterase.

Authors:  Supratik Dutta; Raj K Malla; Saibal Bandyopadhyay; Christopher D Spilling; Cynthia M Dupureur
Journal:  Bioorg Med Chem       Date:  2010-02-04       Impact factor: 3.641

5.  Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition.

Authors:  Vittorio Limongelli; Massimiliano Bonomi; Luciana Marinelli; Francesco Luigi Gervasio; Andrea Cavalli; Ettore Novellino; Michele Parrinello
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-09       Impact factor: 11.205

6.  Action at a distance: mutations of peripheral residues transform rapid reversible inhibitors to slow, tight binders of cyclooxygenase-2.

Authors:  Anna L Blobaum; Shu Xu; Scott W Rowlinson; Kelsey C Duggan; Surajit Banerjee; Shalley N Kudalkar; William R Birmingham; Kebreab Ghebreselasie; Lawrence J Marnett
Journal:  J Biol Chem       Date:  2015-03-30       Impact factor: 5.157

7.  Cyclo-oxygenase-2 contributes to constitutive prostanoid production in rat kidney and brain.

Authors:  Pierre-Olivier Hétu; Denis Riendeau
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

8.  Detergents profoundly affect inhibitor potencies against both cyclo-oxygenase isoforms.

Authors:  Marc Ouellet; Jean-Pierre Falgueyret; M David Percival
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

9.  Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1.

Authors:  Gilad Rimon; Ranjinder S Sidhu; D Adam Lauver; Jullia Y Lee; Narayan P Sharma; Chong Yuan; Ryan A Frieler; Raymond C Trievel; Benedict R Lucchesi; William L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-01       Impact factor: 11.205

10.  Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acid.

Authors:  Jeffery J Prusakiewicz; Kelsey C Duggan; Carol A Rouzer; Lawrence J Marnett
Journal:  Biochemistry       Date:  2009-08-11       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.